Carol B. Bolden

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

Shawn R. Lockhart, Naureen Iqbal, Angela A. Cleveland et al. · Journal of Clinical Microbiology · 2012 · 294 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

Cau D. Pham, Naureen Iqbal, Carol B. Bolden et al. · Antimicrobial Agents and Chemotherapy · 2014 · 230 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility

Shawn R. Lockhart, Naureen Iqbal, Carol B. Bolden et al. · Diagnostic Microbiology and Infectious Disease · 2012 · 71 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent <i>In Vitro</i> Activity against Cryptococcus neoformans and Cryptococcus gattii

Shawn R. Lockhart, Annette W. Fothergill, Naureen Iqbal et al. · Antimicrobial Agents and Chemotherapy · 2016 · 66 citations · Full text

Medicine, Microbiology, Pharmacology +15

Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata

Cau D. Pham, Carol B. Bolden, R J Kuykendall et al. · Journal of Clinical Microbiology · 2013 · 49 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17